Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaffer

Showing results (351-360 of 401) with videos related to

Pageof 41
Sort By:
Clinical and Translational Science|December 25, 2025
Pharmacogenetic hSLCO1B1*14-Guided Dosing of Methotrexate in Transgenic Arthritic Mice Normalizes Exposure and ResponseFelicia Gooden, Brennan D Meier, Griffin D Shaffer, et al.
Foot & Ankle International|January 19, 2018
Quantitative and Qualitative Assessment of the Relative Arterial Contributions to the CalcaneusJohanna C E Donders, Craig E Klinger, Andre D Shaffer, et al.
International Forum of Allergy & Rhinology|October 14, 2023
Elexacaftor-tezacaftor-ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosisAnna C Zemke, Yasmin Hilliam, Amanda L Stapleton, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Respiratory dialysis. A new concept in pulmonary supportB G Hattler, P C Johnson, P J Sawzik, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosisAmanda L Stapleton, Adam J Kimple, Jennifer L Goralski, et al.
Cureus|May 19, 2025
Identifying Barriers to Physical Activity and Exercise Within the Bexar County CommunityMichael D Shaffer, Virgil DeMario, Bailie Moorhead, et al.
International Forum of Allergy & Rhinology|March 2, 2025
Elexacaftor-Tezacaftor-Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic FibrosisAmanda L Stapleton, Adam Kimple, Jennifer L Goralski, et al.
East African Medical Journal|December 13, 2006
Characteristics of HIV infected patients cared for at "academic model for the prevention and treatment of HIV/AIDS" clinics in western KenyaL O Diero, D Shaffer, S Kimaiyo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1996
The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders StudyD Shaffer, P Fisher, M K Dulcan, et al.
International Forum of Allergy & Rhinology|October 28, 2021
Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a cystic fibrosis cohortDaniel R Bacon, Amanda Stapleton, Jennifer L Goralski, et al.
Pageof 41

Showing results (351-360 of 401) with videos related to

Sort By:
Pageof 41
Clinical and Translational Science|December 25, 2025
Pharmacogenetic hSLCO1B1*14-Guided Dosing of Methotrexate in Transgenic Arthritic Mice Normalizes Exposure and ResponseFelicia Gooden, Brennan D Meier, Griffin D Shaffer, et al.
Foot & Ankle International|January 19, 2018
Quantitative and Qualitative Assessment of the Relative Arterial Contributions to the CalcaneusJohanna C E Donders, Craig E Klinger, Andre D Shaffer, et al.
International Forum of Allergy & Rhinology|October 14, 2023
Elexacaftor-tezacaftor-ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosisAnna C Zemke, Yasmin Hilliam, Amanda L Stapleton, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Respiratory dialysis. A new concept in pulmonary supportB G Hattler, P C Johnson, P J Sawzik, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosisAmanda L Stapleton, Adam J Kimple, Jennifer L Goralski, et al.
Cureus|May 19, 2025
Identifying Barriers to Physical Activity and Exercise Within the Bexar County CommunityMichael D Shaffer, Virgil DeMario, Bailie Moorhead, et al.
International Forum of Allergy & Rhinology|March 2, 2025
Elexacaftor-Tezacaftor-Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic FibrosisAmanda L Stapleton, Adam Kimple, Jennifer L Goralski, et al.
East African Medical Journal|December 13, 2006
Characteristics of HIV infected patients cared for at "academic model for the prevention and treatment of HIV/AIDS" clinics in western KenyaL O Diero, D Shaffer, S Kimaiyo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1996
The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders StudyD Shaffer, P Fisher, M K Dulcan, et al.
International Forum of Allergy & Rhinology|October 28, 2021
Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a cystic fibrosis cohortDaniel R Bacon, Amanda Stapleton, Jennifer L Goralski, et al.
Pageof 41